Cortisol, Chronic Stress, and Inflammatory Skin Disease

The relationship between stress and skin disease is well established, yet cortisol physiology is frequently misunderstood. Cortisol is not inherently harmful. It is essential for immune regulation, barrier maintenance, and metabolic balance. Problems arise when cortisol production, timing, or clearance becomes dysregulated.

Cortisol as an Immune Modulator

Cortisol regulates inflammatory signaling by:

• Suppressing excessive cytokine production
• Supporting epidermal barrier repair
• Modulating antimicrobial peptide expression¹

Both elevated and insufficient cortisol can worsen inflammatory skin disease. This explains why patients may flare under chronic stress or during periods of exhaustion.

Diurnal Rhythm Matters

Healthy cortisol follows a predictable daily pattern, peaking shortly after waking and gradually declining throughout the day. Flattened or inverted rhythms are associated with:

• Insomnia
• Chronic fatigue
• Persistent inflammatory skin conditions²

Single serum cortisol measurements cannot assess rhythm or total daily production, limiting their clinical utility.

Cortisol Clearance and Skin Symptoms

Urinary metabolite testing reveals whether cortisol is:

• Overproduced and rapidly cleared
• Underproduced and conserved
• Inappropriately elevated at night

These patterns correlate with symptoms such as nocturnal pruritus, stress-induced flares, delayed wound healing, and poor response to conventional therapies³.

Clinical Implications for Dermatology

Cortisol dysregulation is commonly observed in:

• Chronic eczema and topical steroid withdrawal
• Psoriasis flares linked to psychosocial stress
• Acne resistant to standard treatment
• Rosacea exacerbated by stress triggers

Addressing cortisol rhythm and clearance often improves treatment durability and reduces flare frequency.

References

1. Slominski A, et al. Cortisol and the skin stress response. Physiol Rev. 2013.
2. Chrousos GP. Stress and immune dysregulation. Nat Rev Endocrinol. 2009.
3. Raff H. Utility of urinary cortisol metabolites. Endocrinol Metab Clin North Am. 2015.